Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 with unmodified audit opinions.
Recommended final dividend of ₹62 per equity share for FY26, subject to shareholder approval at AGM on July 23, 2026.
Re-appointed Nitin Rakesh as CEO & MD and Maureen Anne Erasmus as Independent Director for five-year terms effective October and December 2026 respectively.